Turkish scientists developed a test that detects blood incompatibility during pregnancy in 10 minutes!


Prof. Dr. Levent Kayrın and Asst. Assoc. Dr. Umut Kökbaş developed a fast and reliable test method and got a patent.

DANGEROUS TO BABY AND MOM!

Rh incompatibility is a risky situation if the mother’s blood type is Rh negative and the baby is Rh positive. Stating that Rh-positive blood cells belonging to the baby that passed into the mother’s blood during pregnancy stimulate the mother’s immune system and the mother’s body saw these cells as a threat and produced antibodies. Dr. Levent Kayrın said that these antibodies also create a serious danger by breaking down the blood cells of the baby.

For this reason, it is very important to determine whether there is a blood incompatibility between the baby and the mother if the blood type of the mother-to-be is Rh negative and the father is Rh positive. Prof. Dr. Kayrın says that as a precaution in pregnancies with the risk of Rh incompatibility, since Rh determination is a time-consuming and expensive method today, expectant mothers are given a blood incompatibility injection in the 28th week of pregnancy and within 72 hours after birth. The anxiety and stress caused by the risk of blood incompatibility on the mother can also negatively affect the pregnancy.

BLOOD INCOMPATIBILITY CAN BE DETERMINED IN 10 MINUTES

Prof. Dr. Levent Kayrın and Asst. Assoc. Dr. The test method developed by Umut Kökbaş can detect in 10 minutes if there is blood incompatibility in the 8th week of pregnancy.

By applying a nanopolymer-based biosensor system, Turkish scientists can determine the baby’s Rh value within 10 minutes from 5 ml of blood taken from the mother who is at risk of Rh incompatibility. Thus, with the patented new generation test kit, it can be quickly detected whether there is blood incompatibility in the baby. Prof. Dr. Levent Kayrın says that if the blood type of the baby is detected as Rh negative as a result of the test, it indicates that there is no blood incompatibility between the mother and the baby. Prof. Dr. Kayrın stated that in this situation, which does not carry any risk in terms of pregnancy, blood incompatibility injection to the mother, no additional treatment is required and normal follow-up is continued.

Prof. Dr. Levent Kayrın said, “If the blood type of the baby is detected as Rh positive, there is a risk of blood incompatibility between the mother and the baby, and a blood incompatibility injection must be made to protect the baby. Pregnancy is monitored much more closely and ultrasound findings that may cause blood incompatibility in the baby are sought ”.

Asst. Assoc. Dr. On the other hand, Umut Kökbaş emphasizes that being able to find out in advance whether there is a blood incompatibility in her baby will help mothers to have a healthier pregnancy by relaxing them psychologically. Dr. Umut Kökbaş says that by determining the risk of blood incompatibility with the test they developed, they will prevent unnecessary injection to the mother.

WORKS FOR PRODUCTION CONTINUE!

Prof. Dr. Levent Kayrın and Dr. The widespread use of the test method, which Umut Kökbaş developed and patented, will provide great convenience for pregnancies at risk of blood incompatibility. Work continues for the production of the patented test kit. The test kit is planned to be produced and put into use in the near future.


Leave a Reply

Your email address will not be published. Required fields are marked *